Skip to content
Clinical Trials – home
NorwayBack to Norway

Clinical trials in Bergen – page 10

240 clinical trials in Bergen, Norway across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

NorwayOur site in NorwayKliniske-Studier.no(opens in a new tab)
Bergen at a glance
240
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

240 trials in Bergen

Open in trial search

Study on Methotrexate and Dexamethasone for Infants Under One Year with Acute Lymphoblastic Leukemia

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:0–17 years
  • Substances:Asparaginase
  • Sponsor:Prinses Maxima Centrum voor Kinderoncologie B.V.

Study on Tranexamic Acid and Sodium Chloride for Patients with Stroke-Related Brain Bleeding

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:University Of Nottingham

Neuroblastoma

Recruiting

Study of Lutetium (177Lu) Oxodotreotide for Children with Relapsed or Refractory High-Risk Neuroblastoma

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:0–17 years · 18–64 years
  • Substances:Edotreotide
  • Sponsor:Karolinska University Hospital

Study on Hydroxyurea and Valproic Acid or 6-Mercaptopurine with Valproic Acid for Patients with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Hydroxycarbamide
  • Sponsor:Helse Bergen HF

Migraine

Recruiting

Study on Atorvastatin for Preventing Episodic Migraine in Adults

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years
  • Substances:Atorvastatin
  • Sponsor:St. Olavs Hospital HF

Migraine

Recruiting

Study on Atorvastatin for Preventing Chronic Migraine in Adults

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years
  • Substances:Atorvastatin
  • Sponsor:St. Olavs Hospital HF

Study on Atypical Teratoid/Rhabdoid Tumors in Children Using Dactinomycin, Carboplatin, and Cyclophosphamide

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:0–17 years
  • Substances:Carboplatin
  • Sponsor:GPOH gGmbH

Study on the Safety and Effectiveness of VB10.16 and Pembrolizumab for Patients with HPV16-Positive Head and Neck Cancer

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Nykode Therapeutics ASA

Medulloblastoma

Recruiting

Study on the Effectiveness of Bevacizumab and Drug Combination for Children with Recurrent or Progressive Medulloblastoma, Ependymoma, and ATRT

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:0–17 years · 18–64 years
  • Substances:Bevacizumab
  • Sponsor:Medical University Of Vienna

Comparison of ocrelizumab and rituximab treatment in adults with active relapsing-remitting multiple sclerosis

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years
  • Substances:Ocrelizumab
  • Sponsor:Helse Bergen HF

Study on Short vs. Long Immunotherapy with Pembrolizumab and Nivolumab for Patients with High-Risk Skin Melanoma After Surgery

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:North Estonia Medical Centre Foundation

Study on ONC201 and Everolimus with Radiotherapy for Newly Diagnosed Diffuse Intrinsic Pontine Glioma and Other Diffuse Midline Gliomas in Children, Adolescents, and Adults

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Everolimus
  • Sponsor:Institut Gustave Roussy

Other cities in Norway

The busiest research cities in the country

All 54 cities in Norway

Clinical research in Bergen

What the registry says about research in the country

01 Respiratory Medicine

Innovative clinical trials focusing on pulmonary conditions, including studies of new treatments for idiopathic pulmonary fibrosis and childhood respiratory infections.

  • Idiopathic Pulmonary Fibrosis Treatment
  • Pediatric Respiratory Infections
  • Chronic Wet Cough Studies

Research aims to improve lung function and evaluate new therapeutic approaches for both acute and chronic conditions.

02 Oncology Research

Comprehensive studies in cancer treatment, spanning multiple types including hematological malignancies and solid tumors.

  • Multiple Myeloma Therapies
  • Gastric Cancer Treatment
  • Pediatric Liver Cancer

Advanced trials exploring combination therapies and personalized treatment approaches for various cancer types.

03 Autoimmune Disorders

Investigation of novel treatments for inflammatory conditions, with particular focus on gastrointestinal disorders and chronic fatigue syndrome.

  • Crohn's Disease Management
  • ME/CFS Treatment Studies
  • Innovative Diagnostic Methods

Studies aim to improve disease management and develop new diagnostic techniques.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.